Cargando…

Conversion therapy for massive hepatocellular carcinoma: A case report and literature review

KEY CLINICAL MESSAGE: For potentially resectable HCC, a more aggressive conversion therapy strategy (high‐intensity combined with multiple treatment modalities) can be used. ABSTRACT: Hepatocellular carcinoma (HCC) is the sixth most common malignancy worldwide. The best treatment for HCC is radical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Zheyu, Xu, Xiaoliang, Sun, Meiling, Liu, Yang, Liu, Qiaoyu, Chen, Chaobo, Yin, Yin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264960/ https://www.ncbi.nlm.nih.gov/pubmed/37323266 http://dx.doi.org/10.1002/ccr3.7533

Ejemplares similares

A decision tree model to predict liver cirrhosis in hepatocellular carcinoma patients: a retrospective study
por: Zhou, Zheyu, et al.
Publicado: (2023)

A Novel Nomogram for the Preoperative Prediction of Edmondson-Steiner Grade III-IV in Hepatocellular Carcinoma Patients
por: Zhou, Zheyu, et al.
Publicado: (2023)

Contrast-enhanced CT findings-based model to predict MVI in patients with hepatocellular carcinoma
por: Yue, Qi, et al.
Publicado: (2022)

Classification of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma Based on Radiomic Analysis
por: Xu, Xiaoliang, et al.
Publicado: (2022)

Radiomics Analysis on Noncontrast CT for Distinguishing Hepatic Hemangioma (HH) and Hepatocellular Carcinoma (HCC)
por: Hu, Shuyi, et al.
Publicado: (2022)

Long non-coding RNA Myd88 promotes growth and metastasis in hepatocellular carcinoma via regulating Myd88 expression through H3K27 modification
por: Xu, Xiaoliang, et al.
Publicado: (2017)

A commentary on ‘Prothrombin induced by vitamin K Absence-II versus alpha-fetoprotein in detection of both resectable hepatocellular carcinoma and early recurrence after curative liver resection: a retrospective cohort study’ (Int J Surg 2022;105:106843)
por: Zhou, Zheyu, et al.
Publicado: (2023)

Development of conversion therapy for advanced hepatocellular carcinoma
por: Matsuki, Ryota, et al.
Publicado: (2023)

Conversion therapy for unresectable hepatocellular carcinoma after lenvatinib: Three case reports
por: Tomonari, Tetsu, et al.
Publicado: (2020)

Case report: Conversion therapy to permit resection of initially unresectable hepatocellular carcinoma
por: Chen, Kang, et al.
Publicado: (2022)

Chinese expert consensus on neoadjuvant and conversion therapies for hepatocellular carcinoma
por: Zhao, Hai-Tao, et al.
Publicado: (2021)

Downstaging Conversion Therapy in Patients With Initially Unresectable Advanced Hepatocellular Carcinoma: An Overview
por: Sun, Hui-Chuan, et al.
Publicado: (2021)

Solitary skull metastasis as the first symptom of hepatocellular carcinoma: case report and literature review
por: Guo, Xieli, et al.
Publicado: (2014)

Case Report: One-Year Delay in the Effect of Conversion Surgery Therapy for Advanced Hepatocellular Carcinoma After Systemic Therapy
por: Xie, Qing-Yu, et al.
Publicado: (2022)

Conversion therapy for advanced hepatocellular carcinoma with vascular invasion: a comprehensive review
por: Zhang, Zunyi, et al.
Publicado: (2023)

Macrotrabecular-Massive Hepatocellular Carcinoma: What Should We Know?
por: Li, Xiaoming, et al.
Publicado: (2022)

Successful conversion therapy for unresectable hepatocellular carcinoma is getting closer: A systematic review and meta-analysis
por: Pei, Yinxuan, et al.
Publicado: (2022)

Prognostic analysis of hepatocellular carcinoma with macrovascular invasion after liver resection and a successful case of conversion therapy
por: Ji, Mengling, et al.
Publicado: (2022)

The Current Status and Future Prospects for Conversion Therapy in the Treatment of Hepatocellular Carcinoma
por: Bai, Jinfeng, et al.
Publicado: (2023)

Clinical Features and Outcomes of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma
por: Tomonari, Tetsu, et al.
Publicado: (2023)

Nomogram for the Preoperative Prediction of the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma
por: Shan, Yuying, et al.
Publicado: (2022)

Delayed Massive Traumatic Hematoma in the Corpus Callosum: Two Case Reports with Literature Review
por: Du, Yanli, et al.
Publicado: (2014)

Case Report: Massive Hepatocellular Carcinoma Complete Surgical Resection After Portal Vein Embolization and Multimodality Therapy
por: Lin, Qianyi, et al.
Publicado: (2022)

Case report: Condylar metastasis from hepatocellular carcinoma: An uncommon case report and literature review
por: Liu, Xiaojie, et al.
Publicado: (2023)

Neoadjuvant Therapy for Hepatocellular Carcinoma
por: Yin, Zongyi, et al.
Publicado: (2022)

ARRB1 ameliorates liver ischaemia/reperfusion injury via antagonizing TRAF6‐mediated Lysine 6‐linked polyubiquitination of ASK1 in hepatocytes
por: Xu, Xiaoliang, et al.
Publicado: (2020)

Minor hepatectomy for hepatocellular carcinoma in a patient with portal hypertension: A case report and review of the literature
por: Tseng, Ting-Chun, et al.
Publicado: (2022)

Ruptured Massive Hepatocellular Carcinoma Cured by Transarterial Chemoembolization
por: Lee, Ji Eun, et al.
Publicado: (2020)

Mixed Neuroendocrine Carcinoma and Hepatocellular Carcinoma: A Case Report and Literature Review
por: Lan, Jianwei, et al.
Publicado: (2021)

Successful totally laparoscopic right trihepatectomy following conversion therapy for hepatocellular carcinoma: A case report
por: Zhang, Jun-Jing, et al.
Publicado: (2021)

Co-delivery of EGCG and melittin with self-assembled fluoro-nanoparticles for enhanced cancer therapy
por: Sun, Meiling, et al.
Publicado: (2023)

Anesthesia management in a patient with anomalous origin of left pulmonary artery from the descending aorta: A case report and literature review
por: Wang, Lu, et al.
Publicado: (2023)

Sintilimab plus Lenvatinib conversion therapy for intermediate/locally advanced hepatocellular carcinoma: A phase 2 study
por: Wang, Lijun, et al.
Publicado: (2023)

Efficacy of transarterial chemoembolization monotherapy or combination conversion therapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis
por: Li, Weiwei, et al.
Publicado: (2022)

Dual transformation therapy for giant hepatocellular carcinoma: Two case reports and review of literature
por: Gao, Qiang, et al.
Publicado: (2023)

Treatment Strategy for Intermediate-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization, Systemic Therapy, and Conversion Therapy
por: Hatanaka, Takeshi, et al.
Publicado: (2023)

A massive hepatic tumor demonstrating hepatocellular, cholangiocarcinoma and neuroendocrine lineages: A case report and review of the literature
por: Beard, Rachel E., et al.
Publicado: (2017)

Advanced gastrointestinal carcinoma with massive ascites and hydrothorax during pregnancy: A case report and review of the literature
por: Ye, Wenfeng, et al.
Publicado: (2017)

Massive hemothorax caused by intercostal artery pseudoaneurysm:a case report
por: Liu, Caiyang, et al.
Publicado: (2021)

Conversion Therapy for Advanced Pancreatic Cancer: The Case Series and Literature Review
por: Wang, Mingxing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mn7s71bu41h818obaacrrtj80k